Jubilant Pharmova Ltd

K E C International Ltd, Indian Bank, J B Chemicals & Pharmaceuticals Ltd, Birla Corporation Ltd are among the other stocks to see a surge in volumes on BSE today, 13 March 2025.Jubilant Pharmova Ltd registered volume of 47967 shares by 10:47 IST on BSE, a 4.36 fold spurt over two-week average daily volume of 10996 shares. The stock rose 0.28% to Rs.867.70. Volumes stood at 14301 shares in the last session.K E C International Ltd witnessed volume of 94932 shares by 10:47 IST on BSE, a 2.69 times surge over two-week average daily volume of 35267 shares. The stock dropped 4.77% to Rs.680.55. Volumes stood at 1.36 lakh shares in the last session.Indian Bank clocked volume of 56204 shares by 10:47 IST on BSE, a 2 times surge over two-week average daily volume of 28045 shares. The stock lost 0.01% to Rs.493.60. Volumes stood at 19162 shares in the last session.J B Chemicals & Pharmaceuticals Ltd notched up volume of 6934 shares by 10:47 IST on BSE, a 1.94 fold spurt over two-week average daily volume of 3576 shares. The stock rose 1.03% to Rs.1,520.15. Volumes stood at 4591 shares in the last session.Birla Corporation Ltd notched up volume of 14277 shares by 10:47 IST on BSE, a 1.89 fold spurt over two-week average daily volume of 7542 shares. The stock slipped 2.15% to Rs.1,000.25. Volumes stood at 3166 shares in the last session.Powered by Capital Market - Live

The key equity indices traded with modest gains in the morning trade, supported by softer-than-expected inflation data from both the U.S. and India, which eased investor concerns. The Nifty traded above the 22,500 level. PSU bank shares rallied after declining in the past trading session. At 10:30 IST, the barometer index, the S&P BSE Sensex, rose 257.99 points or 0.35% to 74,295.93. The Nifty 50 index added 74.50 points or 0.33% to 22,545. The broader market outperformed the frontline indices. The S&P BSE Mid-Cap index added 0.42% and the S&P BSE Small-Cap index rose 0.40%. The market breadth was negative. On the BSE, 2,195 shares rose and 1,269 shares fell. A total of 167 shares were unchanged. Buzzing Index: The Nifty PSU Bank index jumped 1.10% to 5,822.65. The index dropped 1.08% in the past trading session. Bank of Baroda (up 2.49%), Union Bank of India (up 1.40%), Bank of India (up 1.21%), State Bank of India (up 1.15%), Punjab National Bank (up 0.87%), Punjab & Sind Bank (up 0.84%), Canara Bank (up 0.84%), UCO Bank (up 0.67%), Central Bank of India (up 0.60%) and Indian Overseas Bank (up 0.45%) advanced. Stocks in Spotlight: Jubilant Pharmova rose 0.35%. The company received an establishment inspection report (EIR) from the US Food and Drug Administration (USFDA) with voluntary action indicated (VAI) for its subsidiary's oral formulations facility in Maryland. Yatra Online rallied 3.11% after the company informed that Rohan Purshottamdas Mittal, chief financial officer (CFO) and key managerial personnel (KMP) of the company, has resigned to pursue new opportunities. Firstsource Solutions shed 0.70%. The company announced that its subsidiary, Firstsource Group, USA Inc. has incorporated a new wholly owned subsidiary (WOS), Firstsource Solutions Limited Colombia S.A.S. Powered by Capital Market - Live

The US Food and Drug Administration (USFDA) had classified the inspection as voluntary action indicated (VAI) and confirmed that the inspection is now closed. The inspection took place in January 2025. As per the company's previous disclosure on 18 April 2024, the facility is not expected to manufacture any products as it has closed manufacturing operations. Jubilant Pharmova is engaged in radiopharma, allergy immunotherapy, CDMO of sterile injectable, generics, contract research development and manufacturing (CRDMO) and proprietary novel drugs businesses. The company's consolidated net profit jumped 51% to Rs 100.90 crore during the quarter as compared with Rs 66.80 crore in Q3 FY24. Net sales increased 8.9% YoY to Rs 1,813.70 crore in Q3 FY25. The scrip rose 0.32% to Rs 868 on the BSE.Powered by Capital Market - Live

Net profit of Jubilant Pharmova rose 51.05% to Rs 100.90 crore in the quarter ended December 2024 as against Rs 66.80 crore during the previous quarter ended December 2023. Sales rose 8.92% to Rs 1813.70 crore in the quarter ended December 2024 as against Rs 1665.20 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales1813.701665.20 9 OPM %15.8313.09 - PBDT240.70195.60 23 PBT149.40101.00 48 NP100.9066.80 51 Powered by Capital Market - Live

Jubilant Biosys Innovative Research Services, Singapore (JBIRSPL), a subsidiary of Jubilant Biosys, a wholly owned subsidiary of Jubilant Pharmova, has executed the transaction definitive agreements with Pierre Fabre SA, and its affiliate entities (PF), for JBIRSPL to acquire 80% equity capital in JASMIN (new company incorporated by PF in France, as a Soci't' par Actions Simplifi'e (SAS)), with remaining 20% retained by PF. In respect of an application made by JBIRSPL (for the said acquisition of 80% equity in JASMIN), the French Ministry of Economy and Finance has asserted that the Transaction is not subject to foreign investment control in France. At closing of the transaction, JASMIN shall acquire PF's R&D Centre (including R&D Site and R&D activities) at Saint Julien, France, and JBIRSPL would also execute a Shareholders' Agreement and other transition agreements with PF. Powered by Capital Market - Live

Jubilant Pharmova will hold a meeting of the Board of Directors of the Company on 31 January 2025.Powered by Capital Market - Live

In an exchange filing made today, the company informed that the United States Food and Drug Administration (US FDA) had conducted an inspection at the aforementioned facility. Post the inspection, the drug regulator issued five observations with no repeat observations. Jubilant Cadista will submit an appropriate action plan to the USFDA on these observations within stipulated time,' Jubilant Pharmova stated. Jubilant Pharmova is engaged in radiopharma, allergy immunotherapy, CDMO of sterile injectable, generics, contract research development and manufacturing (CRDMO) and proprietary novel drugs businesses. The company's consolidated net profit jumped 64.48% to Rs 102.80 crore on a 4.53% increase in revenue to Rs 1742.20 crore in Q2 FY25 as compared with Q2 FY24. The scrip rose 0.25% to currently trade at Rs 924.20 on the BSE. Powered by Capital Market - Live

Jubilant Pharmova announced that its subsidiary Jubilant Cadista Pharmaceuticals Inc., (Jubilant Cadista)'s solid oral formulations facility at Salisbury, Maryland, USA was inspected by the United States Food and Drug Administration (USFDA). USFDA has issued five observations with no repeat observations. Jubilant Cadista will submit an appropriate action plan to the USFDA on these observations within stipulated time. Going forward the said facility is not expected to manufacture any products as it has closed manufacturing operations as was referenced in the previous disclosure dated 18 April 2024. Powered by Capital Market - Live

Sun Pharma Advanced Research Company Ltd, Five-Star Business Finance Ltd, The Ramco Cements Ltd, Aditya Birla Real Estate Ltd are among the other stocks to see a surge in volumes on BSE today, 16 December 2024.Jubilant Pharmova Ltd notched up volume of 5.34 lakh shares by 10:46 IST on BSE, a 29 fold spurt over two-week average daily volume of 18403 shares. The stock slipped 2.06% to Rs.1,093.20. Volumes stood at 17130 shares in the last session.Sun Pharma Advanced Research Company Ltd saw volume of 2.23 lakh shares by 10:46 IST on BSE, a 8.53 fold spurt over two-week average daily volume of 26087 shares. The stock increased 9.15% to Rs.231.45. Volumes stood at 21924 shares in the last session.Five-Star Business Finance Ltd registered volume of 96529 shares by 10:46 IST on BSE, a 2.68 fold spurt over two-week average daily volume of 36031 shares. The stock rose 3.43% to Rs.671.50. Volumes stood at 38641 shares in the last session.The Ramco Cements Ltd witnessed volume of 37604 shares by 10:46 IST on BSE, a 2.52 times surge over two-week average daily volume of 14922 shares. The stock increased 0.47% to Rs.1,045.80. Volumes stood at 36870 shares in the last session.Aditya Birla Real Estate Ltd clocked volume of 8626 shares by 10:46 IST on BSE, a 2.19 times surge over two-week average daily volume of 3939 shares. The stock gained 2.40% to Rs.2,818.25. Volumes stood at 3690 shares in the last session.Powered by Capital Market - Live

Net profit of Jubilant Pharmova rose 64.48% to Rs 102.80 crore in the quarter ended September 2024 as against Rs 62.50 crore during the previous quarter ended September 2023. Sales rose 4.53% to Rs 1742.20 crore in the quarter ended September 2024 as against Rs 1666.70 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1742.201666.70 5 OPM %16.6114.51 - PBDT250.00194.60 28 PBT158.6098.00 62 NP102.8062.50 64 Powered by Capital Market - Live